of the airways due to an abnormality in nervous control mechanisms. Physiological studies showing that electrical stimulation of the vagus caused bronchoconstriction and that stimulation of the nasal mucosa produced reflex bronchoconstriction in animals gave strong support to this idea (Dixon & Brodie 1902) . In 1910 Melzer suggested that because the asthmatic attack was similar to anaphylactic shock in guinea pigs, asthma could be explained by immunological mechanisms. Since then two opposing schools of thought have prevailed: physiologists emphasized the hyperreactivity of asthmatic airways to diverse nonimmunological stimuli, whereas immunologists stressed the antigen-induced release of mast cell mediators as the primary abnormality. Current evidence suggests that mast cell mediator release and abnormalities in autonomic control of the airways interact and contribute to the bronchoconstriction of asthma. There are many precipitating causes for an asthmatic attack including allergen exposure, infection, exercise, psychological stress, and administration of drugs such as IJ-blockers and aspirin; these are not the cause of the underlying condition, but reflect the way in which asthmatic airways respond to a variety of stimuli. Several theories of pathogenesis have been proposed.
Mediator theory
Mast cell mediators: Many asthmatics are atopic and form IgE antibody on exposure to common allergens. Specific IgE binds to high affinity Fe receptors on mast cells in the respiratory tract. Specific antigen, such as grass pollen, cross-links bound IgE molecules and results in an increase in membrane fluidity and uncovering of calcium channels, which allow the influx of calcium ions (Ishizaka et al. 1981) . This leads to the rapid release of preformed mediators, such as histamine, and the elaboration of lipid mediators. Studies on human lung fragments indicated that several prostaglandins, including PGE 2 , PGF2~' prostacyclin and thromboxane A 2, were released with antigen challenge, but since they were also released after exposure to the cholinergic agonist methacholine, it suggested that release of these prostaglandins may have been secondary to smooth muscle contraction (Platshon & Kaliner 1978) . Recent studies have shown that PGD 2 is the major prostaglandin product released from human lung mast cells (Lewis et al. 1981) . Activation of mast cells also leads to the release of slow-reacting substance of anaphylaxis, which is now known to be made up of lipoxygenase products of arachidonic acid metabolism, the leucotrienes. LTD 4 is the most potent bronchoconstrictor leucotriene, and LTB 4 is a highly potent neutrophil chemotactic factor. Leucotrienes may also be secreted from cells other than mast cells, including macrophages and neutrophils. Platelet-activating factor (acetyl glyceryl ether phosphoryl choline) attracts platelets, which release vasoactive amines such as serotonin, and also has direct smooth muscle contractile effects (Findlay et al. 1981) . Activation of mast cells also results in the release of peptide chemotactic factors which recruit inflammatory cells such as neutrophils, mononuclear cells and eosinophils. Activated neutrophils release Iysozymes and 'Accepted 7 December 1982 0141-0768/83/070580-07/$01.00/0 r{) 1983 The Royal Society of Medicine eosinophils release major basic protein, which contribute to mucosal oedema (Gleich et al. 1979 ). This inflammatory response may contribute to the late reaction which occurs several hours after antigen challenge. This late response, which may involve airway inflammation and glandular hypersecretion in addition to smooth muscle spasm, may be more like chronic asthma than the early response to antigen challenge which is due to smooth muscle spasm and is easily reversible. Recently it has been demonstrated that the action of different mediators may be synergistic. In vitro histamine has an amplifying effect on the smooth muscle contractile response to leucotrienes (Piper et al. 1981) , and in vivo bradykinin and histamine are synergistic in the skin (Basran et al. 1982) , and PGE 2 and histamine in the airways (Walters et al. 1982) . It is likely that there is an extremely complex interaction between various mediators which results in an amplification of their effects.
Non-immunological release of mediators: Although mediators are involved in allergeninduced asthma, many non-immunological stimuli also provoke bronchoconstriction. There has been considerable debate over whether these stimuli involve the release of mediators from mast cells. Exercise is a common precipitant of bronchoconstriction in asthmatic subjects, and the initiating stimulus appears to be cooling of the airways as a result of hyperventilation (Deal et al. 1979) . Using a sensitive assay for histamine, a rise in plasma .concentration was found with exercise in asthmatics, but not in normal controls (Barnes & Brown 1981) . However, when the same subjects hyperventilated at rest, producing the same degree of bronchoconstriction, there was no increase in plasma histamine. This suggests that the rise in exercise may emanate from circulating basophils, which increase during exercise. Neutrophil chemotactic factor, another mast cell mediator, also rose with exercise in asthmatic but not normal subjects (Lee et al. 1982) , but failed to rise on hyperventilation challenge at rest. It is possible that mediator is released in the airway wall, but is not detectable in the circulation. Further evidence for mediator release in exercise-induced asthma is that cromoglycate, which stabilizes mast cells in vitro, protects against exercise-and hyperventilation-induced asthma. There is a refractory period following exercise-induced asthma, during which a second exercise challenge provokes less bronchoconstriction, and this may be indirect evidence for local mediator release and depletion. A similar refractoriness is seen in some patients following hyperventilation challenge (Wilson et al. 1982) . Whether mediator release is also involved in other non-immunological challenges with agents such as sulphur dioxide, ozone, inert dusts or ultrasonically nebulized water has not yet been established. The mechanism by which non-immunological stimuli cause release of mediators is not fully understood. In cold urticaria, physical stimuli such as pressure, vibration or cold exposure lead to histamine release from the skin and a marked elevation in plasma histamine concentration (Soter et al. 1980) . Basophils from asthmatics are more likely to release histamine spontaneously than those from normal subjects (Findlay & Lichtenstein 1980) , and an elevated plasma histamine has been found in both atopic and non-atopic (intrinsic) asthmatics under resting conditions (Barnes et al. 1982b ), suggesting that basophils, and by implication mast cells, may be abnormally 'leaky' in asthma. Various physical stimuli may then lead to further mediator release from these abnormal cells.
Neurogenic theory
The simple concept that asthma results from the interaction of antigen with antibody failed to explain the observations that mediators such as histamine had only trivial effects in normal subjects, that many asthmatics had no evidence of allergy, that many atopic subjects were not asthmatic, and that many non-immunological stimuli caused bronchoconstriction. The exaggerated bronchoconstriction to non-immunological stimuli could be inhibited by atropine, which blocks post-ganglionic vagal pathways, suggesting the involvement of a neural reflex in the constrictor response.
In dogs, mechanical and chemical stimulation of nerve endings in airway epithelium caused reflex bronchoconstriction, which was abolished either by cutting thevagus nerve, Of by administration of atropine (Nadel & Widdicombe 1962) . When Ascaris antigen was given to one lung of Ascaris-sensitive dogs, there was bilateral bronchoconstriction which was abolished by ipsilateral cooling of the vagus nerve (Gold et al. 1972 ). This suggested that mast cell mediator release caused bronchoconstriction, not by a direct effect on airway smooth muscle, but by an indirect vagal reflex effect. Vagal reflex mechanisms may also be important in human bronchoconstriction. In normal subjects, respiratory virus infections (Empey et al. 1976 ) and ozone (Holtzman et al. 1979) caused an exaggerated airway response to inhaled histamine, and this was abolished by atropine. Since both viral infections and ozone cause epithelial damage, it suggested that stimulation of epithelial irritant receptors caused reflex bronchoconstriction. It further suggested that airway hyperreactivity in asthma may be due to a sensitization of these reflex responses, a hypothesis which could be tested by the effect of anticholinergic drugs on asthmatic bronchoconstriction. There has been much debate about the importance of vagal mechanisms in asthma, and many of the conflicting results depend on the different selection of patients for study. In asthmatic subjects the exaggerated bronchoconstrictor response to sulphur dioxide, ozone and inert dusts was abolished by atropine (Simonsson et al. 1967) . However atropine did not block the bronchoconstriction caused by antigen in the same subjects in whom it blocked the response to methacholine and citric acid (Rosenthal et al. 1977) . Thus reflex bronchoconstriction explains only some of the features of asthma. The airway epithelium is impermeable to antigens, so that the rapid response to both irritants and antigens is likely to be related to a process occurring at the airway surface. It has been postulated that there is a small population of luminal mast cells which release mediators that then activate surface irritant receptors, and also increase the permeability of the airway so that antigen may now penetrate to the larger number of mast cells in the submucosa (Hogg et al. 1977) . In monkeys there is some evidence that antigen challenge in sensitized animals produces an increase in mucosal permeability and increased sensitivity to histamine (Boucher et al. 1979 ), but there is not yet any convincing evidence for an increase in airway permeability in human asthma.
Arguing against the importance of vagal reflex mechanisms in the pathogenesis of asthma is the observation that cholinergic antagonists, although effective in inhibiting the acute bronchoconstricting effects of irritants, are not very effective in treating asthma. Although to some extent this may be because insufficiently high doses of these agents are used, it may also be because the reflex component of bronchoconstriction may be important where smooth muscle spasm is a major component of bronchoconstriction. This may be overemphasized by studies in which mild cases of asthma are selected for investigation. In a study of refractoriness in hyperventilation-induced asthma, it was found that in those subjects with refractoriness (and therefore presumed to have mediator release) bronchoconstriction could not be blocked by a cholinergic antagonist, whereas those with no refractoriness could be blocked, suggesting that in these subjects reflex mechanisms were predominant (Wilson et al. 1982) . It seems likely that both reflex mechanisms and mediator release are involved in the pathogenesis of asthmatic bronchoconstriction, and that mediator release assumes a more important role as asthma increases in severity.
Autonomic imbalance theory
Airway smooth muscle is regulated by the autonomic nervous system: cholinergic and aadrenergic stimulation cause contraction, whereas p-adrenergic stimulation causes relaxation. An imbalance in autonomic control, with excitatory influences predominating over inhibitory effects, might therefore underlie bronchial hyperreactivity. In addition, antigen-induced release of mast cell mediators is influenced by autonomic agonists, with pagonists reducing and a-adrenergic and cholinergic agonists facilitating release. Airway submucosal glands and capillaries are also regulated by the autonomic nervous system. Thus an imbalance in autonomic regulation could account for many of the features of asthma.
Beta-adrenoceptors: On the basis of animal models which have little similarity to asthma, Szentivanyi (1968) proposed that a fundamental defect in atopy was a reduced {J-adrenergic responsiveness. Such a concept was supported by the finding that {J-blockers caused bronchoconstriction in asthmatic but not in normal subjects (Zaid & Beall 1966) . Early studies showed that metabolic and cardiovascular responses to {J-agonists were indeed reduced in asthmatic subjects (Cookson & Reed 1963 , Middleton & Fink 1968 , Logsdon et al. 1972 , and direct binding studies showed a reduced density of p-receptors on circulating lymphocytes of asthmatics (Brooks et al. 1979) . However, similar reductions in p-adrenergic responses and {J-receptor density were produced in both normal and asthmatic subjects by administration of p-agonists (Nelson et al. 1975 , Jenne et al. 1977 , Conolly & Greenacre 1976 , Galant et al. 1980 ), suggesting that the impaired p-adrenergic responsiveness in asthmatic subjects may be explained by tachyphylaxis as a result of prior adrenergic bronchodilator therapy. However, there are some reports of a small impairment in {Jadrenergic responsiveness in asthmatics who have not been treated, or in whom treatment has been withdrawn for over four weeks (Apold & Aksnes 1977 . The mechanism of this impairment is uncertain, but is unlikely to be due to circulating catecholamines, since their concentration in stable asthmatics is normal (Barnes et al. 1982h) . A circulating factor was identified in the sera of some asthmatics which inhibited preceptor binding (Venter et al. 1980) , but the significance of this {J-blocking factor is uncertain as it has been found in only a small proportion of atopic asthmatics and has also been detected in non-atopic normal subjects.
Studies of p-adrenergic function in tissues remote from the airways may not reflect an abnormality of {J-receptors in the airways. It is difficult to compare directly airway responses to p-agonists in asthmatics and normal subjects because of difficulties in interpretation when airway obstruction is present. When {J-adrenergic metabolic, cardiovascular and airway responses were measured over a 24-hour period in asthmatics with nocturnal wheezing, there was no impairment in responsiveness at night when bronchoconstriction was maximal (Barnes et al. 1982a) . Thus there is no convincing evidence for a major defect in {J-receptor function in asthma. Furthermore, chronic treatment of normal subjects with {J-blockers does not produce either atopy or asthma, so that any impairment in {J-receptor function is likely to be secondary to some other abnormality.
Circulating catecholamines: Beta-adrenergic function is presumably regulated by endogenous adrenaline, and a deficiency in circulating adrenaline could thus contribute to bronchoconstriction, in the same way that {J-blockers produce bronchoconstriction in asthmatics. Circulating adrenaline concentrations were not reduced in stable asthmatics compared with normal controls at rest (Barnes et al. 1982h) and their circadian rhythms were not abnormal (Barnes et al. 1980b) , but there was an impairment in the catecholamine response to exercise in asthmatics (Barnes et al. 198Ia) . ' Alpha-adrenoceptors: There is considerable evidence that a-adrenergic responsiveness may be increased in asthma. Alpha-agonists cause bronchoconstriction in asthmatic but not in normal subjects (Snashall et al. 1978 , Black et al. 1982 . In vitro z-agonists had no effect on normal human or dog airways, but if precontracted with histamine there was a marked bronchoconstrictor response (Kneussl & Richardson 1978) . Similar constrictor responses were also seen in diseased human airways without prior incubation with histamine. This suggests that histamine and airway disease are in some way able to activate airway aadrenergic responses. This activation did not involve a change in airway smooth muscle areceptors, but appeared to be via a post-receptor mechanism, possibly involving calcium ion flux (Barnes et al. '1983) . In an experimental model of asthma and in human chronic airway Obstruction a marked increase in a-receptor density in peripheral lung homogenates was found (Barnes et al. 1980 a.c) . These changes in a-responsiveness and receptors cannot be the primary abnormality, but must be the consequence of some event such as the release of mast cell mediators. The a-adrenergic hyperresponsiveness in asthma may be generalized, since asthmatic subjects were found to have greater pupillary and cutaneous vascular responses to locally applied c-agonists (Henderson et al. 1979 ).
Cholinergic receptors: The airways of asthmatics are hyperreactive to inhaled cholinergic agonists and the bronchoconstriction induced by nonspecific stimuli may be blocked by atropine as discussed above. This may indicate hyperreactivity of cholinergic pathways in asthma. In atopic subjects with hyperreactivity, the increased reactivity to inhaled histamine was inhibited by the ganglion blocker hexamethonium, whereas that to the cholinergic agonist methacholine was not (Holtzman et al. 1980) . This indicates that the site of hyperresponsiveness was postganglionic and could be at the level of smooth muscle cholinergic receptors or in the muscle itself. There is also evidence for a generalized cholinergic hyperresponsiveness, as cholinergic agonists induced greater sweating and pupillary responses in asthmatics than in normal controls (Kaliner 1976 .
Non-adrenergic inhibitory nervous system:
In the presence of cholinergic and adrenergic blockade, nerve stimulation causes relaxation of airway smooth muscle in several species, including man (Richardson & Beland 1976) . In man it is the principal inhibitory nervous system and it has been suggested that its function may be impaired in asthma. It is difficult to obtain evidence for this since neither the neurotransmitter nor the neural pathways are known, and no specific blocker is available. The most likely candidate for neurotransmitter is vasoactive intestinal peptide (VIP), which is present in nerves supplying airway smooth muscle and glands (Ghatei et al. 1982) , and there is convincing evidence for its function as an inhibitory neurotransmitter in guinea pig trachea (Matsuzaki et al. 1980) .
Smooth muscle abnormality theories
Hypertrophy and hyperplasia of airway smooth muscle occur in asthmatic patients, and these alterations may play a role in the hyperreactivity of asthma in the same way that increased thickness of the vascular wall may contribute to the increased responsiveness to constrictor agents in hypertension. Furthermore, the electrophysiological properties may be altered in asthma, so that the muscle is more excitable. Antonissen et al. (1979) demonstrated that airway smooth muscle from dogs chronically sensitized to Ascaris antigen showed spontaneously increasing tone with phasic contractile activity and active tension after stretching. Such changes were not seen in control animals, which suggests that they may be produced in airway smooth muscle by exposure to mast cell mediators. Electron microscopic studies have shown that excitation of canine airway smooth muscle may result in the formation of more gap junctions, which may make the muscle more excitable as neural impulses would spread more widely (Karman & Daniel 1980) . If airway smooth muscle from asthmatics had more gap junctions, this might explain the exaggerated response to diverse stimuli.
Calcium theory
Mast cell mediator secretion, smooth muscle contraction and airway gland secretion are all calcium dependent processes. As these functions are abnormal in asthma, it has been suggested that there may be an increase in calcium ion transport across the cell membrane (Middleton 1980) . Although there is no direct evidence for this hypothesis, the effects of calcium antagonists such as nifedipine and verapamil have been investigated. Calcium antagonists inhibit airway smooth muscle contraction to histamine (Coburn 1977) and reduce antigen-induced release of mediators from human lung in vitro (Lee et al. 1983 ).
Although they have no effect on baseline bronchoconstriction in asthmatics (Williams et al. 1981, Barnes et al. 198Ib ), there is a small but significant protection against histamineinduced bronchoconstriction , and significant protection against exercise-induced asthma (Cerrina et al. 1981 , Barnes et al. 1981b , Patel 1981 . However, calcium entry into cells is the final common path of many cellular processes and there is nothing to suggest a specific defect in asthma.
General conclusions
The pathogenesis of asthma is complex and it may be difficult to account for all the features of the disease by a single mechanism. Most evidence now points to a defect in the airway mast cells as the primary abnormality. Mediators of inflammation which are abnormally released by these mast cells can account for all the pathological features of asthma, including contraction of airway smooth muscle, hypersecretion of airway submucosal glands and inflammation of the airway wall. The mechanism by which non-immunological stimuli bring about mediator release is. uncertain, but indicates an abnormality in the mast cell. Bronchoconstrictor mediators may have indirect effects by stimulating afferent nerve fibres to produce reflex bronchoconstriction, thus amplifying the effects of mediators, but this reflex component may become less important in severe asthma where the direct effects of mediators assume a more important role. The autonomic abnormalities that have been described in asthma are unlikely to be a primary abnormality, but may be produced by the effects of mediators on autonomic receptors. The reduced p-adrenergic and increased 0(adrenergic and cholinergic responsiveness would further contribute to bronchoconstriction. Prolonged exposure to mediators may lead to smooth muscle and gland hypertrophy and to electrophysiological changes in these end organs, so that the increased excitability becomes permanent and may persist even in the absence of mediator release.
